Quem quiser entender um pouco melhor sobre os resultados, tem uma apresentacao para o Q2:
Varian Medical Systems, Inc. 2019 Q2 - Results - Earnings Call Slides - Varian Medical Systems, Inc. (NYSE:VAR) | Seeking AlphaPR Newswire
PALO ALTO, Calif., April 24, 2019 /PRNewswire/ --
Second Quarter 2019 Summary
– Oncology gross orders grew 15% in dollars, or 18% in constant currency
– Total company revenues grew 7% in dollars, or 10% in constant currency, to $779 million
– GAAP operating earnings grew 1% at 14.1% of revenues; Non-GAAP operating earnings declined 6% at 15.3% of revenues
– GAAP net earnings per diluted share of $0.96; Non-GAAP net earnings per diluted share of $1.05
– Recently enacted US/China tariffs negatively impacted revenue growth by $9 million or 120 basis points and GAAP operating earnings growth by $13 million or 160 basis points
– Raising revenue growth range for fiscal year 2019 guidance; reaffirming Non-GAAP net earnings per diluted share range of $4.60 to $4.75
